SAM #36E79726R0021

VA Solicitation for Acamprosate Calcium Enteric Coated Tablets, 333mg, 180-count Bottles

This opportunity involves the Department of Veterans Affairs (VA) National Acquisition Center's procurement of Acamprosate Calcium Enteric Coated Tablets for federal healthcare agencies. - Government Buyer: - Department of Veterans Affairs (VA), National Acquisition Center (NAC Pharmaceuticals, 36E797) - Supports VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC) - Products Requested: - Acamprosate Calcium Enteric Coated Tablets, 333mg strength - Packaged in 180-count bottles (unit-of-use) - Estimated annual quantity: 33,661 bottles - No specific OEMs or vendors named; open to all qualified manufacturers - Unique/Notable Requirements: - Each product must have a unique National Drug Code (NDC) number and label - Packaging must include safety caps and meet specific bottle dimension requirements - Product must be suitable for distribution to VA Consolidated Mail Order Pharmacies (CMOPs) and State Veterans Homes (SVH) - Contract Structure: - One-year base period with four one-year option periods (up to five years total) - Place of Performance/Delivery: - Primary contracting office: NAC Pharmaceuticals, Hines, IL 60141

Description

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79726R0021 for an unrestricted procurement for Acamprosate Calcium (CA) Enteric Coated (EC) Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DoD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere over the successful offeror/contractor's label. This product requires unit of use packaging, as identified in the Schedule of Supplies (Line item 1, 180-count bottles). The bottles shall contain a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation #36E79726R0021 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about May 7, 2026, with a tentative closing date of May 21, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at SAM.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Deb Fassl. Questions can be e-mailed to Deborah.Fassl@va.gov. The estimated annual requirements are as follows:

REQUIREMENT DESCRIPTION ITEM DESCRIPTION UNIT of USE

PKG. SIZE (Tablets per Bottle) TOTAL EST. ANNUAL USAGE (Bottles) 1 ACAMPROSATE CA EC 333MG TAB Y 180 33,661

View original listing